Erectile Dysfunction Severity as a Risk Marker for Cardiovascular Disease Hospitalisation and All-Cause Mortality: A Prospective Cohort Study

English version České info

Background:
Erectile dysfunction is an emerging risk marker for future cardiovascular disease (CVD) events; however, evidence on dose response and specific CVD outcomes is limited. This study investigates the relationship between severity of erectile dysfunction and specific CVD outcomes.

Methods and Findings:
We conducted a prospective population-based Australian study (the 45 and Up Study) linking questionnaire data from 2006–2009 with hospitalisation and death data to 30 June and 31 Dec 2010 respectively for 95,038 men aged ≥45 y. Cox proportional hazards models were used to examine the relationship of reported severity of erectile dysfunction to all-cause mortality and first CVD-related hospitalisation since baseline in men with and without previous CVD, adjusting for age, smoking, alcohol consumption, marital status, income, education, physical activity, body mass index, diabetes, and hypertension and/or hypercholesterolaemia treatment. There were 7,855 incident admissions for CVD and 2,304 deaths during follow-up (mean time from recruitment, 2.2 y for CVD admission and 2.8 y for mortality). Risks of CVD and death increased steadily with severity of erectile dysfunction. Among men without previous CVD, those with severe versus no erectile dysfunction had significantly increased risks of ischaemic heart disease (adjusted relative risk [RR] = 1.60, 95% CI 1.31–1.95), heart failure (8.00, 2.64–24.2), peripheral vascular disease (1.92, 1.12–3.29), “other” CVD (1.26, 1.05–1.51), all CVD combined (1.35, 1.19–1.53), and all-cause mortality (1.93, 1.52–2.44). For men with previous CVD, corresponding RRs (95% CI) were 1.70 (1.46–1.98), 4.40 (2.64–7.33), 2.46 (1.63–3.70), 1.40 (1.21–1.63), 1.64 (1.48–1.81), and 2.37 (1.87–3.01), respectively. Among men without previous CVD, RRs of more specific CVDs increased significantly with severe versus no erectile dysfunction, including acute myocardial infarction (1.66, 1.22–2.26), atrioventricular and left bundle branch block (6.62, 1.86–23.56), and (peripheral) atherosclerosis (2.47, 1.18–5.15), with no significant difference in risk for conditions such as primary hypertension (0.61, 0.16–2.35) and intracerebral haemorrhage (0.78, 0.20–2.97).

Conclusions:
These findings give support for CVD risk assessment in men with erectile dysfunction who have not already undergone assessment. The utility of erectile dysfunction as a clinical risk prediction tool requires specific testing.

Please see later in the article for the Editors' Summary

Vyšlo v časopise: Erectile Dysfunction Severity as a Risk Marker for Cardiovascular Disease Hospitalisation and All-Cause Mortality: A Prospective Cohort Study. PLoS Med 10(1): e32767. doi:10.1371/journal.pmed.1001372
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001372

Souhrn

Zdroje

1. ThompsonIM, TangenCM, GoodmanPJ, ProbstfieldJL, MoinpourCM, et al. (2005) Erectile dysfunction and subsequent cardiovascular disease. JAMA 294: 2996–3002.

2. KingA (2010) Erectile dysfunction and CVD. Nat Rev Cardiol 7: 241.

3. World Health Organization (2011) Global status report on noncommunicable diseases 2010. Geneva: World Health Organization.

4. HelfandM, BuckleyD, FreemanM, FuR, RogersK, et al. (2009) Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Int Med 151: 496–507.

5. InmanBA, SauverJLS, JacobsonDJ, McGreeME, NehraA, et al. (2009) A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clinic Proc 84: 108–113.

6. BlumentalsWA, Gomez-CamineroA, JooS, VannappagariV (2003) Is erectile dysfunction predictive of peripheral vascular disease? Aging Male 6: 217–221.

7. DongJY, ZhangYH, QinLQ (2011) Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol 58: 1378–1385.

8. GuoW, LiaoC, ZouY, LiF, LiT, et al. (2010) Erectile dysfunction and risk of clinical cardiovascular events: a meta-analysis of seven cohort studies. J Sex Med 7: 2805–2816.

9. HotalingJM, WalshTJ, MacleodLC, HeckbertSR, PocobelliG, et al. (2012) Erectile dysfunction is not independently associated with cardiovascular death: data from the Vitamins and Lifestyle (VITAL) Study. J Sex Med 9: 2104–2110.

10. BattyG, LiQ, CzernichowS, NealB, ZoungasS, et al. (2010) Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. J Am Coll Cardiol 56: 1908–1913.

11. BanksE, RedmanS, JormL, ArmstrongB, BaumanA, et al. (2008) Cohort profile: the 45 and up study. Int J Epidemiol 37: 941–947.

12. National Centre for Classification in Health (2006) International statistical classification of diseases and related health problems, 10th revision, Australian modification (ICD-10-AM)—fifth edition. Sydney: National Centre for Classification in Health.

13. National Centre for Classification in Health (2007) The Australian Classification of Health Interventions (ACHI), 6th edition. Tabular list of interventions and alphabetic index of interventions. Sydney: National Centre for Classification in Health.

14. QuanH, ParsonsGA, GhaliWA (2004) Assessing accuracy of diagnosis-type indicators for flagging complications in administrative data. J Clin Epidemiol 57: 366–372.

15. BoyleCA, DobsonAJ (1995) The accuracy of hospital records and death certificates for acute myocardial infarction. Aust N Z J Med 25: 316–323.

16. TirschwellDL, LongstrethWTJr (2002) Validating administrative data in stroke research. Stroke 33: 2465–2470.

17. TengTH, FinnJ, HungJ, GeelhoedE, HobbsM (2008) A validation study: how effective is the Hospital Morbidity Data as a surveillance tool for heart failure in Western Australia? Aust N Z J Public Health 32: 405–407.

18. RuigomezA, Martin-MerinoE, RodriguezLA (2010) Validation of ischemic cerebrovascular diagnoses in the health improvement network (THIN). Pharmacoepidemiol Drug Saf 19: 579–585.

19. DerbyCA, AraujoAB, JohannesCB, FeldmanHA, McKinlayJB (2000) Measurement of erectile dysfunction in population-based studies: the use of a single question self-assessment in the Massachusetts Male Aging Study. Int J Impot Res 12: 197–204.

20. Population Health Division (2010) The health of the people of New South Wales: summary report—report of the Chief Health Officer. Sydney: New South Wales Department of Health. Available: http://www0.health.nsw.gov.au/pubs/2010/pdf/chorep_summary_2010.pdfwww.health.nsw.gov.au/publichealth/chorep/. Accessed (17 Dec 2012).

21. FayMP, FeuerEJ (1997) Confidence intervals for directly adjusted rates: a method based on the gamma distribution. Stat Med 16: 791–801.

22. Australian Institute of Health and Welfare (2003) The Active Australia Survey: a guide and manual for implementation, analysis and reporting. Canberra: Australian Institute of Health and Welfare.

23. NgSP, KordaR, ClementsM, LatzI, BaumanA, et al. (2011) Validity of self-reported height and weight and derived body mass index in middle-aged and elderly individuals in Australia. Aust N Z J Public Health 35: 557–563.

24. SAS Institute (2011) SAS version 9.3 [computer program]. Cary (North Carolina): SAS Institute.

25. SchoutenBWV, BohnenAM, BoschJLHR, BernsenRMD, DeckersJW, et al. (2008) Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen Study. Int J Impot Res 20: 92–99.

26. AraujoAB, TravisonTG, GanzP, ChiuGR, KupelianV, et al. (2009) Erectile dysfunction and mortality. J Sex Med 6: 2445–2454.

27. LueTF (2000) Erectile dysfunction. N Engl J Med 342: 1802–1813.

28. SolomonH, ManJ, JacksonG (2003) Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 89: 251–253.

29. JacksonG, RosenRC, KlonerRA, KostisJB (2006) The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med 3: 28–36.

30. HerbertK, LopezB, CastellanosJ, PalacioA, TamarizL, et al. (2008) The prevalence of erectile dysfunction in heart failure patients by race and ethnicity. Int J Impot Res 20: 507–511.

31. AbhayaratnaW, SmithW, BeckerN, MarwickT, JeffreyI, et al. (2006) Prevalence of heart failure and systolic ventricular dysfunction in older Australians: the Canberra Heart Study. Med J Aust 184: 151–154.

32. HuangN, DaddoM, CluneE (2009) Heart health—CHD management gaps in general practice. Aust Fam Physician 38: 241–245.

33. HoldenC, McLachlanR, PittsM, CummingRG, WittertG, et al. (2005) Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men. Lancet 366: 218–224.

34. MealingN, BanksE, JormL, SteelD, ClementsM, et al. (2010) Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs. BMC Med Res Methodol 10: 26.

35. ChewKK, FinnJ, StuckeyB, GibsonN, SanfilippoF, et al. (2010) Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings from a linked-data study. J Sex Med 7: 192–202.

36. AraujoAB, HallSA, GanzP, ChiuGR, RosenRC, et al. (2010) Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score? J Am Coll Cardiol 55: 350–356.

37. MittlemanMA, GlasserDB, OrazemJ (2003) Clinical trials of sildenafil citrate (Viagra) demonstrate no increase in risk of myocardial infarction and cardiovascular death compared with placebo. Int J Clin Pract 57: 597–600.